ABSTRACT A biological monitoring programme has been developed for assessing occupational exposure to 4,4'-methylenebis (2-chloroaniline) ( 
Aromatic amines are in a class of chemical compounds that contain proved potent carcinogens. The chemical structure of 4,4'-methylenebis (2-chloroaniline) (MBOCA) (fig la) is similar to benzidine (fig lb) , a diamine known to induce malignant bladder tumours in man' and with a structural similarity to 3,3'-dichlorobenzidine, which has been shown to be carcinogenic in several animal species. 2 In the mid 1950s MBOCA was introduced into the polyurethane industry and has since become a commercially important hardener or curing agent used in manufacturing certain isocyanate based polyurethane elastomers. Since MBOCA is an aromatic amine it has come under close toxicological investigation. MBOCA possesses the general toxic characteristics of aromatic amines and may produce cyanosis from methaemoglobin formation.3 Of greater concern are the results from animal bioassays in which it has been shown that MBOCA is carcinogenic in three animal species, rats,4 mice,5 and dogs.6 In view of the animal data, and further evidence on the mutagenic7 and genotoxic8 nature of MBOCA, the compound has been cited as a potential human carcinogen. Munn molten MBOCA, indicated that most of the material was excreted in the urine within 24 hours, with a peak excretion reaching about 600 nmol MBOCA/mmol creatinine. '3 In 1972 the American Conference of Industrial Hygienists listed MBOCA as an "experimental carcinogen" and proposed a threshold limit value of 0-02 ppm (220 ,ug/m3). '4 In 1975 the ACGIH revised their classification and MBOCA was listed under "occupational substances suspected of oncogenic potential for workers." ''5 A discussion of the control measures that should be taken when handling MBOCA was presented by Henning. '6 In 1978 the Health and Safety Executive recommended that the threshold limit value should be lowered from 220 Ug/m3 to 50 ,ug/m3 (8h TWA). These limits referred to atmospheric levels of MBOCA, but since a possible route of absorption was believed to be through the skin it carried a skin notation. '7 In the same year NIOSH proposed that no worker should be exposed to air concentrations in excess of 3 gg/m3. '8 In this paper we report the urinary MBOCA results from workers occupationally exposed to MBOCA over a five year period.
Experimental details FACTORY PROCESS
The factory is in the United Kingdom and manufactures certain polyurethane plastics, which have good resilience and load bearing properties. Polyurethane is made from an isocyanate prepolymer and a curing agent. MBOCA is used As a curing agent that cross links the polymer chains. It is supplied as pellets, which are melted (120°C) before being blended with the preheated liquid polymer. After pouring the molten mixture into a mould it is allowed to harden in an oven for about an hour. The articles are removed from the moulds and receive a final curing in an oven. The number of employees engaged in urethane production has been remarkably stable over the past five years. The company employs 12-15 men in a variety of tasks including handling the raw materials and molten MBOCA, preparing the polymer, removing products from the moulds, machining and handling the finished products, and general cleaning and maintenance. The men are trained in all aspects of the job and a rotation policy is in operation. Production of polyurethane products has been relatively constant over the five year period.
BIOLOGICAL MONITORING
In 1978 a systematic biological monitoring programme was initiated and the workforce were asked to provide regular monthly urine samples. These samples were collected from the entire workforce on the same day and dispatched immediately to the laboratory for analysis. Samples were deep frozen and analysed within three days. Using the method of Gristwood et al, '9 without the hydrolysis stage, MBOCA was extracted from the urine with diethyl ether under alkaline conditions, and after derivatisation with heptafluorobutyryl chloride was analysed by electron capture gas chromatography. Creatinine in urine was measured using the Jaffe reaction on an autoanalyser. 20 The results were expressed in nmol MBOCA/mmol creatinine (detection limit 1 nmol MBOCA/mmol creatinine; the coefficient of variation was typically 8%). In addition, morning and afternoon urine samples were collected for five consecutive days from two process workers in October and November 1978. The same exercise was repeated in August 1981 with another worker who was engaged in general duties but was not handling MBOCA directly.
Results
The histogram (fig 2) 3a) . After improvements to the ventilation and the introduction of some protective clothing some improvement is seen in the urinary results. This is shown by a change in the histogram pattern where the modal value has been shifted to about 10 nmol MBOCA/mmol creatinine (fig 3b) . The pronounced improvements from late 1979 may be associated with the, introduction of a dry cleaning scheme for the overalls. There was a significant increase in the number of workers who were found to have no MBOCA in their urine (fig 3c) (fig'3d) .
In an attempt to identify problem areas within the factory two process workers with consistently high , 50^.
urinary MBOCA concentrations were monitored twice daily for one week on two separate occasions in October and November 1978 (fig 4a, b) . As yet, little is known regarding the kinetics and metabolism of MBOCA in man. We have noted that rapid fluctuations occur throughout the working week. MBOCA is probably metabolised in man and the use of these metabolites for monitoring absorption of MBOCA into the body may be more appropriate than measurement of unchanged MBOCA. '9 Although the significance of the urinary MBOCA results is unknown it would seem prudent to minimise exposure by operating in a clean dust free and fume free environment and to use adequate protective clothing that is regularly cleaned so that all possible routes which may lead to skin absorption may be reduced to a minimum. We conclude that a regular biological monitoring surveillence programme can help identify any deviation from the recommended operating procedures.
